Can Teenagers Use GLP-1 Medications?
Last updated: January 2026
Quick Answer
Wegovy is FDA-approved for adolescents 12+ with obesity. Tirzepatide is not yet approved for under-18. Prescribing for teenagers is becoming more common at specialty centers but remains controversial. Not prescribed via standard telehealth platforms.
Can Teenagers Use GLP-1 Medications
Wegovy is FDA-approved for adolescents 12+ with obesity. Tirzepatide is not yet approved for under-18. Prescribing for teenagers is becoming more common at specialty centers but remains controversial. Not prescribed via standard telehealth platforms.
GLP-1 medication eligibility is determined by your healthcare provider based on your BMI, health conditions, and medical history. The FDA guidelines provide the framework, but individual providers may have additional criteria or be willing to evaluate borderline cases.
Standard Eligibility Criteria
- BMI of 30 or higher (obese)
- BMI of 27 or higher with at least one weight-related comorbidity
- Common qualifying comorbidities: type 2 diabetes, hypertension, dyslipidemia, sleep apnea, PCOS
- No contraindications such as medullary thyroid carcinoma history or MEN 2 syndrome
The Evaluation Process
Your telehealth provider will review your health history, current medications, and weight management goals. Most online assessments take under 10 minutes. If you qualify, a licensed prescriber will create a treatment plan tailored to your specific needs and health profile.
If you are unsure whether you qualify, many telehealth providers offer free initial assessments with no obligation. This allows you to find out if GLP-1 treatment is appropriate for you without any financial risk.
Related Questions
Who Qualifies for GLP-1 Medications?
FDA criteria: BMI ≥30, or BMI ≥27 with at least one weight-related condition (high blood pressure, T2D, sleep apnea, high cholesterol). Telehealth providers apply similar criteria. You need a prescription from a licensed physician.
Are GLP-1 Medications Safe for Long-Term Use?
GLP-1 medications have been studied for up to 5 years with acceptable safety profiles. Long-term data continues to accumulate as these medications become more widely used.